Cookie Consent by Privacy Policies website
Cannabis SeedsAutoflower SeedsOutdoorseedsCBD SeedsRegular Weed SeedsAccessories
20+ Years Experience
Discreet Shipping
Bonus Seeds
Canna Wiki

THCV: Effects, Properties & Differences from THC

What Is THCV? Effects, Meaning and Differences from THC

Updated: July 2026 | What is THCV? Effects, differences from THC, occurrence, properties, and the scientific classification of this cannabinoid.
Author: Cannapot Grow Team | Reading time: approximately twenty-two minutes

Molecular models of THCV and THC in direct comparison

The Most Important Points at a Glance

THCV stands for tetrahydrocannabivarin and is a naturally occurring phytocannabinoid found in the cannabis plant.

THCV resembles THC in its chemical structure but has a shorter side chain. This difference significantly affects how it interacts with cannabinoid receptors.

The effects of THCV cannot simply be described as “non-intoxicating” or “stimulating.” They depend, among other factors, on the dose, route of administration, product composition, and individual response.

Evidence suggesting effects on appetite and glucose metabolism comes mainly from cell and animal models and a few small human studies. No proven benefit for weight loss or diabetes treatment has been established.

For an objective assessment, laboratory results and the full composition of a product are more informative than marketing terms such as “Diet Weed” or “Energy Cannabinoid.”

THCV Is a Distinct Cannabinoid, Not Merely a Weaker Form of THC

THCV is short for tetrahydrocannabivarin. The compound belongs to the phytocannabinoids, meaning cannabinoid-like substances found in plants grown from cannabis seeds Although its name and molecular framework resemble delta-9-tetrahydrocannabinol, THCV is not a pharmacologically interchangeable substitute for THC.

The key difference lies in the molecule’s side chain: THCV has a propyl chain with three carbon atoms, while THC has a pentyl chain with five carbon atoms. This difference affects how strongly and in what manner the molecule binds to targets in the endocannabinoid system. As a result, THCV and THC can produce different and sometimes opposing effects despite their chemical relationship.

What Exactly Is THCV?

THCV is a less common plant cannabinoid found in measurable amounts mainly in certain cannabis genetics.

In the fresh plant, the compound is generally not present directly as neutral THCV. Instead, the plant first produces the acidic precursor tetrahydrocannabivarinic acid (THCVA). Through heat, prolonged storage, or other processing methods, THCVA can release carbon dioxide and be converted into THCV. This process is known as decarboxylation.

THCV belongs to the group known as varin cannabinoids. This class of compounds has a shorter side chain than the better-known pentyl cannabinoids. In addition to THCV, varin cannabinoids include CBDV and CBGV, among others. The term “varin” refers solely to a chemical structure and does not indicate a particular effect. Cannabis strains rich in THCV are still relatively rare. Well-known exceptions include, for example, V-Auto THCV from Humboldt Seed Company and Diet Durban THCV 1:1 from Seedsman. In addition, the Dutch breeder Dutch Passion offers a strain called THC Victory a strain very rich in THCV. Many of these THCV-rich strains are offered as feminized seeds. This generally eliminates the need to distinguish early between male and female cannabis plants .

How Is THCV Produced in the Cannabis Plant?

THCV is produced through its own biosynthetic pathway, whose starting materials differ from those used in conventional THC formation.

Whereas THC is formed from cannabigerolic acid (CBGA), cannabigerovarinic acid (CBGVA) serves as the starting material for the biosynthesis of varin cannabinoids. Specific enzymes convert CBGVA into tetrahydrocannabivarinic acid (THCVA), among other compounds. Neutral THCV is formed only after decarboxylation.

Whether a cannabis plant produces meaningful amounts of THCV is determined primarily by its genetics. Growing conditions, maturity, harvest timing, drying, and storage subsequently affect the concentration that can actually be measured. A strain name alone is therefore not sufficient to reliably predict a high THCV content.

How Does THCV Act in the Body?

THCV affects several biological targets in a dose- and assay-dependent manner, with its interaction with CB1 and CB2 receptors being the best studied.

The CB1 receptor is especially abundant in the central nervous system and plays a major role in the typical psychoactive effects of THC. In experimental models, THCV can reduce or block activation of this receptor under certain conditions. Other findings suggest that at higher concentrations or in certain experimental systems, THCV may also develop agonistic, meaning activating, properties.

In laboratory studies, THCV has been described as a partial agonist at the CB2 receptor. CB2 receptors are found mainly in immune-system cells and various peripheral tissues. However, receptor data of this kind do not directly demonstrate that THCV affects a particular disease in humans. Several stages of testing separate an effect in a cell model from a clinically relevant benefit.

Is THCV Psychoactive or Intoxicating?

THCV cannot reliably be classified as completely non-psychoactive, but at the low doses studied it appears to have a different effect profile from THC.

Psychoactive simply means that a substance can affect perception, mood, or other functions of the central nervous system. The term is not synonymous with intense intoxication. Evidence suggests that low doses of THCV may partially reduce typical THC effects. At the same time, preclinical data indicate that higher doses may trigger THC-like signals under certain conditions.

Human research to date is too limited to support general conclusions about the intoxicating effects of THCV. Claims such as “THCV always makes you feel clear and focused” or “THCV is never intoxicating” cannot be clearly substantiated by the current state of research.

How Does THCV Differ from THC?

THCV and THC differ mainly in their side chains, receptor activity, natural occurrence, and the strength of the clinical evidence.

Feature THCV Delta-9-THC
Full name Tetrahydrocannabivarin Delta-9-Tetrahydrocannabinol
Side chain three carbon atoms five carbon atoms
CB1 activity complex and dose-dependent; antagonistic or neutral-antagonistic in many models, and partially agonistic under other conditions partial agonist; activates CB1 and mediates key intoxicating effects
Typical psychoactive effect not fully characterized in humans; likely highly dependent on dose and product well established and often clearly noticeable
Occurrence usually low, higher in selected genetics often the main cannabinoid in THC-dominant chemovars
Appetite preclinical evidence of a reduction; no robust evidence of weight loss in small human studies can affect appetite and food intake; effect depends on dose and context
Medical status not an established single active ingredient for a generally accepted standard therapy established in certain medicines and medical applications, depending on country and indication

The table shows why THCV should not be described as “THC light” or as light cannabis Although both molecules belong to the same broader family of compounds, they do not automatically trigger the same biological responses.

Infografik „THCV und THC: Struktur, Rezeptoren und Forschungsstand

Why Does a Shorter Side Chain Change the Effects So Much?

The length and shape of the side chain affect how well a cannabinoid binds to a receptor and how stable the resulting receptor–compound complex is.

THCV has a propyl side chain with three carbon atoms, whereas delta-9-THC has a pentyl side chain with five carbon atoms. THCP even has a heptyl side chain with seven carbon atoms. These structural differences influence lipophilicity, spatial fit, and binding strength at cannabinoid receptors, among other factors. They explain some of the differing pharmacological properties, but they are not the only factors involved. The molecule’s three-dimensional arrangement, dosage, tissue studied, and signaling proteins involved also play important roles.

In brief: THCV differs from THC partly because THCV has a shorter side chain. This structural feature affects binding to cannabinoid receptors and is an important reason for the different pharmacological properties of the two cannabinoids.

How Is THCV Absorbed and Processed in the Body?

Like other fat-soluble cannabinoids, THCV is absorbed by the body at different rates depending on the route of administration and is then metabolized mainly in the liver.

When inhaled, a cannabinoid usually reaches the bloodstream faster than when taken orally. Orally ingested substances first pass through the stomach and intestines and then the liver. This first-pass effect can reduce the amount of unchanged active compound while producing active or inactive metabolites. Comprehensive human pharmacokinetic studies of delta-9-THCV are lacking, so its half-life, bioavailability, and dose–response relationships have not yet been reliably standardized.

Its fat solubility promotes distribution into lipid-rich tissues. How long THCV or its metabolites remain detectable may depend on the dose, frequency of use, body composition, liver function, and testing method, among other factors. Findings on THC should not be transferred to THCV without verification.

Can THCV Alter the Effects of THC?

THCV can influence THC signaling in experimental models, but the direction and strength depend on dose, ratio, timing, and biological system.

Because THCV blocks the CB1 receptor at low concentrations in many preclinical models, it has been suggested that it might reduce certain effects of THC. Preclinical studies provide initial support for this possibility. However, this does not mean that a cannabis product containing THCV and THC will necessarily be less intoxicating.

In plant material and extracts such as hashish many compounds act at the same time. Absorption rate and metabolism also vary depending on the method of consumption. Without controlled human studies of specific THCV-to-THC ratios, precise predictions remain uncertain.

Does THCV Suppress Appetite?

Preclinical studies suggest that THCV may suppress appetite. However, sufficient clinical evidence that THCV reliably reduces hunger or causes weight loss in humans is still lacking.

The popular term “Diet Weed” is based mainly on preclinical studies and THCV’s known receptor profile. Small human studies have observed changes in neural responses to pleasant and unpleasant stimuli. However, these imaging studies do not demonstrate that THCV reliably reduces calorie intake or leads to long-term weight loss.

In a controlled study of people with type 2 diabetes, pure THCV had no significant effect on body weight or reported food intake. Based on current research, THCV is therefore not suitable as a weight-loss product or as a substitute for established medical treatment.

What Is the Significance of THCV for Glucose Metabolism?

Initial human studies have produced some interesting metabolic signals, but they are not sufficient to recommend THCV for the prevention or treatment of diabetes.

A randomized, placebo-controlled pilot study investigated THCV and CBD strains in people with type 2 diabetes. Changes in fasting blood glucose and certain markers of beta-cell function were reported with THCV. However, other key outcomes, including the primary endpoint HDL cholesterol, body weight, and insulin sensitivity, did not show consistently convincing improvements.

The studies conducted so far were small and of limited duration. Their results provide a basis for further research, but not proof of an effective therapy. People with diabetes should therefore not replace prescribed medication or recommended dietary measures with THCV.

Is THCV Stimulating or Does It Improve Concentration?

A reliably stimulating or concentration-enhancing effect of THCV has not been clinically demonstrated in humans.

Reports of increased alertness, clarity, or concentration often come from personal accounts or cannabis product marketing. Such observations may provide clues, but they do not replace controlled scientific studies. Factors such as THC content, other cannabinoids, accompanying compounds, caffeine, dosage, and a person’s condition on a given day can also substantially influence perception.

An fMRI study showed that a single dose of THCV altered brain responses to rewarding and aversive stimuli. However, this does not demonstrate a general improvement in performance. Targeted neuropsychological studies are required for robust conclusions about attention, reaction time, or everyday functioning.

Image showing inflammation, pain, nervous system, movement, motor function, bone, and tissue
 

What Other Effects of THCV Are Being Studied?

THCV is being investigated in research on inflammation, pain, neuroprotection, bone metabolism, and movement disorders, among other areas. However, the available evidence is based predominantly on preclinical studies.

Inflammation and Pain

Changes in inflammatory processes and pain-related responses have been observed in preclinical animal models. However, these results do not establish an analgesic or anti-inflammatory effect of THCV in humans.

Nervous System

Cell and animal studies suggest that THCV may have neuroprotective properties. Whether these effects occur in humans remains unclear, as do appropriate dosing and long-term safety.

Movement and Motor Function

Some preclinical studies suggest that THCV may influence motor symptoms. However, sufficiently large controlled human studies are lacking.

Bone and Tissue

Laboratory studies suggest that THCV may influence cell growth and cell differentiation. However, current research does not show whether this could provide a medical benefit in humans.

A common misunderstanding is to equate biological activity with proven medical efficacy. A substance can influence biological processes in a test tube or in animal models without providing a clinically relevant benefit in humans. Clinical studies must therefore establish whether an observed effect is genuinely effective, reproducible, and safe.

Where Does THCV Occur Naturally?

THCV occurs only in trace amounts in many cannabis plants but can be much more pronounced in genetically selected lines.

The literature more frequently describes cannabis lines geographically associated with landraces from parts of Africa and Asia as possible sources of varin-rich profiles. However, such origin claims are no guarantee. Modern crosses may retain or lose these traits, and the same strain name may refer to different chemotypes depending on the producer.

Only a current laboratory analysis of the specific batch can provide a reliable answer. THCVA and THCV should be reported separately. For estimating the content after heating, a calculated total value may also be useful, provided the conversion method is stated transparently.

How Is THCV Content Measured in the Laboratory?

THCV and THCVA are usually measured chromatographically, with HPLC capable of detecting the acidic and neutral forms separately.

In high-performance liquid chromatography (HPLC), the sample is analyzed without intense heating. This makes it possible to reliably distinguish THCVA from THCV. In gas chromatography (GC), by contrast, the sample is often heated, so acidic cannabinoids may partially decarboxylate during analysis. The laboratory should therefore always state the analytical method and calculation basis used.

In addition to the measured THCV content, the limit of quantification, measurement uncertainty, sampling method, and laboratory accreditation are important. A result just above the detection limit is far less meaningful than a reproducibly verified concentration.

What Happens During the Decarboxylation of THCVA into THCV?

During decarboxylation, THCVA loses a carboxyl group in the form of carbon dioxide and becomes the neutral cannabinoid THCV.

The reaction is accelerated by heat but can also occur slowly during prolonged storage Temperature and time affect not only the conversion but also possible degradation processes. Intense or prolonged heating therefore does not necessarily produce a higher usable THCV content.

For laboratory reports, this means that the directly measured THCV value describes the already neutral form. THCVA is reported separately. A calculated total value accounts for the mass lost by the acid molecule during decarboxylation. The formula used should be stated in the certificate of analysis.

How Stable Is THCV During Exposure to Light, Heat, and Storage?

Like other cannabinoids, THCV can be altered by light, oxygen, heat, and prolonged storage, although specific stability data are much more limited than for THC and CBD.

Cannabinoid profiles are not unchanging snapshots. After the cannabis harvest chemical processes continue. Acidic precursors decarboxylate, and neutral cannabinoids can oxidize or degrade under unfavorable conditions. Airtight storage protected from light and temperature fluctuations slows many of these reactions but does not guarantee unlimited stability.

With older certificates of analysis, the actual composition may therefore differ from the original measurement. Batch identification and the date of analysis are important for a serious quality assessment.

How Does THCV Differ from CBDV, THCP, CBGV, and HHC?

Although THCV belongs to the cannabinoid family alongside several well-known compounds, it differs from them in biosynthesis, structure, receptor profile, and available evidence.

Compound Structural classification Key difference from THCV
CBDV varin relative of CBD with a propyl side chain does not have the THC-typical baseline profile at the CB1 receptor and is studied in other research areas
THCP THC homolog with seven carbon atoms in the side chain shows substantially higher CB1 binding affinity in laboratory studies; human evidence is very limited
CBGV varin relative of CBG lies on a different biosynthetic branch and has a different pharmacological profile
HHC hydrogenated THC analogue; often chemically manufactured in products is not a varin cannabinoid and can produce distinctly THC-like psychoactive effects
Delta-8-THCV positional isomer of delta-9-THCV differs in the position of a double bond; data on pharmacokinetics and effects remain incomplete

Similar names do not indicate comparable effects. Especially for newly marketed cannabinoids, chemical identity, manufacturing route, purity, and independent laboratory analyses should each be evaluated separately.

What Side Effects and Risks Are Possible with THCV?

The safety profile of isolated THCV has not yet been comprehensively established because only a few, mostly small, human studies are available.

THCV has so far been studied only for limited periods and under controlled conditions. It is therefore not currently possible to make robust statements about rare side effects, long-term use, high doses, or possible interactions. Potential effects may include discomfort, changes in mood or perception, dizziness, fatigue, nausea, and effects on heart rate and circulation. Which effects actually occur depends, among other factors, on the dose, any THC present at the same time, and other ingredients.

Particular caution is advised during pregnancy and breastfeeding, in adolescents, and for people with cardiovascular disease, pre-existing mental health conditions, or concurrent medication use. Adequate safety data are not available for these groups. Anyone with health concerns or ongoing medical treatment should discuss use with a physician.

Can THCV Interact with Medications?

Interactions between THCV and medicines are possible in principle but have so far been insufficiently studied.

Like other cannabinoids, THCV is metabolized in the liver through various enzyme systems. If a medicine uses the same enzymes or THCV affects their activity, drug levels could theoretically change. However, robust clinical data on possible interactions are lacking for many medication classes.

Particular caution is required with medicines that have a narrow therapeutic range and with drugs that affect blood glucose, blood pressure, blood clotting, mood, or alertness. THCV should therefore not be combined with prescription medicines without medical advice.

Can THCV Be Detected in Drug Tests?

There is no universal answer as to whether THCV can be detected in a drug test. Standard rapid tests are designed primarily to detect THC metabolites, not THCV specifically.

Specialized laboratory methods can distinguish THCV and its characteristic metabolites. Standard urine tests, by contrast, primarily react to the THC metabolite THC-COOH. Because many THCV products also contain THC or may be contaminated with THC, there is a risk of a positive test result regardless of any possible cross-reactivity.

Anyone who is regularly drug-tested for occupational, sporting, or legal reasons should therefore not regard THCV products as a test-free alternative to THC.

Which Claims About THCV Are Not Scientifically Supported?

Claims of guaranteed weight loss, reliable performance enhancement, treatment of type 2 diabetes, or completely side-effect-free action go beyond the current state of scientific research.

Claim: THCV is a natural appetite suppressant.
Preclinical studies provide interesting indications. However, controlled human studies have not yet demonstrated a reliable reduction in food intake or body weight.

Claim: THCV works like THC, only without the high.
THCV has a different receptor profile from THC and may act differently depending on the dose. It is therefore not simply a weaker form of THC.

Claim: THCV treats type 2 diabetes.
A small pilot study found changes in individual metabolic parameters, but it does not provide sufficient evidence of efficacy for therapeutic use.

Claim: THCV increases energy and concentration.
Sufficiently large controlled studies using objective performance and attention tests are still lacking for this claim.

Claim: More THCV automatically means a better effect.
A higher THCV content can alter the effect profile, but it does not automatically produce a stronger effect, greater benefit, or better tolerability.

How Strong Is the Scientific Evidence on THCV?

The evidence on THCV is relatively solid for basic chemistry and receptor pharmacology, but low to very low for specific health applications.

Research question Predominant evidence base Assessment
Chemical structure and biosynthesis analytical chemistry, enzyme research, plant biochemistry well described
CB1 and CB2 pharmacology cell models, tissue experiments, animal studies plausible, but dose- and model-dependent
appetite and body weight mainly animal models, a few small human studies no established clinical benefit
glucose metabolism preclinical data and small pilot studies research signal, not a treatment recommendation
focus, energy, and performance enhancement anecdotal reports and indirect data not established
long-term safety insufficient human data unresolved

A 2025 study of a combined THCV–CBD formulation reported changes in body weight. Because several active compounds were used together and product-specific factors may have played a role, no clear effect of isolated THCV can be inferred. Such findings should be confirmed by independent studies with clearly defined comparison groups.

How Can the Quality of THCV Claims Be Assessed?

Reliable THCV information is batch-specific, transparently documented, and clearly separates analytical measurements from marketing claims.

  • The certificate of analysis reports THCV and THCVA separately.

  • The batch number on the product matches the batch number on the certificate of analysis.

  • The analytical method, laboratory, test date, and limits of quantification are stated.

  • In addition to THCV, THC, other cannabinoids, and relevant contaminants are reported.

  • No guaranteed medical effects or cure claims are made.

A high THCV content alone says little about product quality. What matters is transparent analytical testing, reliable measurements, and information about other ingredients and possible contaminants.

What Does Research Currently Know with Confidence About THCV?

What is established above all is that THCV is a distinct phytocannabinoid with complex receptor pharmacology; many practical health claims remain unresolved.

The chemical structure, the plant precursor THCVA, and the interaction with cannabinoid receptors are well documented. It is also plausible that its effect profile differs from THC. Claims regarding long-term safety, optimal dosage, interactions, and clinical benefit are considerably more uncertain.

Human research on THCV to date consists of only a few studies with small participant groups. Although cannabis has a long history THCV remains comparatively understudied scientifically. Larger, independent, long-term studies using standardized preparations are required for robust conclusions. Until then, a cautious scientific assessment is more appropriate than definitive claims about potential benefits.

Frequently Asked Questions About THCV

What does the abbreviation THCV mean?
THCV stands for tetrahydrocannabivarin, a natural cannabinoid found in the cannabis plant.

Is THCV the same as THC?
No. The two molecules are related, but they differ in their side chains and in their effects at cannabinoid receptors.

What is THCVA?
THCVA is tetrahydrocannabivarinic acid, the acidic precursor of THCV in the plant. It can be converted into THCV through decarboxylation.

Does THCV make you high?
A universal answer is not possible based on current research. Low doses often do not show the effect profile typical of THC, while higher doses may have psychoactive properties under certain conditions. However, human research remains too limited for general conclusions.

Is THCV an appetite suppressant?
Animal and laboratory studies provide indications, but a reliable appetite-suppressing or weight-reducing effect in humans has not been established.

Can THCV help with diabetes?
A small study provided initial indications of changes in certain metabolic markers. However, there is currently insufficient scientific evidence to use THCV to treat type 2 diabetes.

Does every cannabis strain contain THCV?
THCV can be detected in many cannabis strains, but it is often present only in trace amounts. Higher THCV levels are found mainly in certain genetic lines.

Can a laboratory distinguish THCV from THC?
Yes. Suitable chromatographic methods can measure THCV, THC, and their acidic precursors separately.

Is THCV safe?
The available safety data on THCV are limited. In particular, sufficient scientific evidence is lacking on long-term use, high doses, use during pregnancy and breastfeeding, use in adolescents, and possible interactions with medicines.

Is THCV unproblematic for drug testing?
No. THCV products may also contain THC or be contaminated with THC. Specialized laboratory methods can also detect THCV and its metabolites. A negative drug-test result therefore cannot be guaranteed.

Which Technical Terms Are Important for Understanding THCV?

The following terms help with understanding and interpreting studies, certificates of analysis, and product information relating to THCV.

Agonist
A substance that activates a receptor and thereby triggers a biological response.
Antagonist
A substance that blocks or reduces activation of a receptor without activating it in the same way.
Partial agonist
An active compound that activates a receptor but produces a lower maximum effect than a full agonist even when all receptors are occupied.
CB1 receptor
A cannabinoid receptor that is particularly abundant in the nervous system and plays a major role in the psychoactive effects of THC.
CB2 receptor
A cannabinoid receptor found in immune cells and various peripheral tissues, among other locations.
Phytocannabinoid
A plant-produced compound that can interact with the endocannabinoid system or related biological targets.
Chemovar
A classification of cannabis based on its measurable chemical profile rather than solely on a strain name.
Decarboxylation
A chemical reaction in which a cannabinoid acid releases carbon dioxide and converts into its neutral form.
Bioavailability
The proportion of an administered substance that reaches the systemic circulation unchanged.
Metabolite
A metabolic product formed when an original substance is enzymatically transformed in the body.

Putting THCV in Perspective: Interesting for Research, but Not a Cure-All

THCV expands scientific understanding of the cannabis plant, but its significance is often overstated in public discussion.

THCV differs substantially from THC and has a complex, dose-dependent receptor profile. These very characteristics make the cannabinoid an interesting subject of research. At the same time, they show that simplistic labels such as “non-intoxicating THC,” “weight-loss cannabinoid,” or “natural focus booster” do not reflect current scientific knowledge.

For an objective assessment of THCV, it is important to distinguish between laboratory research, animal studies, human studies, and clinically proven applications. Current research provides interesting indications and justifies further scientific investigation, but it does not provide a basis for cure claims or guaranteed effects.

Scientific Sources

  • Jadoon KA et al. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes. Diabetes Care. 2016. PubMed
  • Pertwee RG et al. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids. British Journal of Pharmacology. 2008. PubMed
  • Bolognini D et al. The plant cannabinoid Delta-9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. British Journal of Pharmacology. 2010. PubMed
  • Tudge L et al. Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers. International Journal of Neuropsychopharmacology. 2015. PubMed
  • McPartland JM et al. Are cannabidiol and Delta-9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? British Journal of Pharmacology. 2015. PubMed
  • ElSohly MA et al. Delta-9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol. Journal of Analytical Toxicology. 2001. PubMed
  • Kayir H et al. Tetrahydrocannabivarin Dose Dependently Blocks or Substitutes for the Discriminative Stimulus Effects of THC in Rats. 2025. PubMed
  • Haghdoost M et al. Tetrahydrocannabivarin is Not Tetrahydrocannabinol. Cannabis and Cannabinoid Research. 2025. PubMed
  • Tahir MN et al. The biosynthesis of the cannabinoids. Journal of Cannabis Research. 2021. PubMed
  • Walsh KB et al. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. 2021. PubMed
  • Das PC et al. Postharvest Operations of Cannabis and Their Effect on Cannabinoid Content. 2022. PubMed
J. von Cannapot

J. Cannapot

J. is the founder of Cannapot and is regarded as an expert in the field of cannabis with a focus on cannabis strains. He has extensive knowledge about the topic as well as many years of experience in the industry. For many years, J. has been deeply involved with strains and various cannabis products in the field of hemp and cannabis.

Info

Biohazard by Archive Seeds

Biohazard smells very intensely of sweet incense and notes of biscuits, with a biting touch of Chemdog - all together a spice mixture that you have to love. It is a cross between Skunk VA Chem 91 and the legendary DoSiDos, an easy-to-grow blend that even complete beginners can grow...